LAS VEGAS, NV--(Marketwired - May 12, 2014) - Alkame Holdings, Inc. (
"Tops Markets and other leading grocers are always looking for new and exciting opportunities to expand their current product selections to provide an even better shopping experience for their loyal customers," commented Robert K. Eakle CEO of Alkame Water. "Not all waters are created equal, so we strongly believe that our patented Alkame ultimate health and wellness water formulation is an excellent fit for Tops Markets and should prove to be popular with all their customers seeking out healthy products that can noticeably improve their daily lives."
About Tops Holdings, LLC
Tops Markets, LLC, is headquartered in Williamsville, NY and operates 159 full-service supermarkets -- 154 company-owned and five franchise locations under the Tops banner. With more than 15,000 associates, Tops is a leading full-service grocery retailer in upstate New York, northern Pennsylvania, and western Vermont. For more information about Tops Markets, visit the company's website at www.topsmarkets.com.
About Alkame Holdings, Inc.
Alkame Holdings, Inc. is a publicly traded health and technology holding company with a focus on patentable, innovative, and eco-friendly consumer products. The Company's wholly-owned subsidiary, Alkame Water, Inc., markets and distributes micro-clustered, alkaline, antioxidant and oxygenated bottled water utilizing an exclusive patented formula and technology. Alkame's patented technology creates water with several unique properties which allow the body to absorb and utilize it more efficiently and help to achieve an optimal pH balance. The patented Alkame technology also increases the available oxygen content and absorbability which equates to more fuel for improved metabolic efficiency, boosted immune system, and improved cardio respiratory function.
Not all waters are created equal™. For more information, visit www.alkamewater.com.
Disclaimer/Safe Harbor: This news release contains forward-looking statements within the meaning of the Securities Litigation Reform Act. The statements reflect the Company's current views with respect to future events that involve risks and uncertainties. Among others, these risks include the expectation that Tops Markets will achieve significant additional distribution for the Company's products, the failure to meet schedule or performance requirements of the Company's contracts, the Company's liquidity position, the Company's ability to obtain new contracts, the emergence of competitors with greater financial resources and the impact of competitive pricing. In the light of these uncertainties, the forward-looking events referred to in this release might not occur. These statements have not been evaluated by the Food and Drug Administration. These products are not intended to diagnose, treat, cure or prevent any disease.